
ROMERIO ALESSIO
Pubblicazioni
Franco, A., Aladailleh, Z., Romerio, A., Italia, A., Lami, F., Shaik, M., et al. (2025). Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists. RSC MEDICINAL CHEMISTRY [10.1039/D4MD00950A]. Dettaglio
Shirey, K., Romerio, A., Shaik, M., Leake, D., Palmer, C., Skupinska, N., et al. (2025). Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection. INNATE IMMUNITY, 31 [10.1177/17534259241313201]. Dettaglio
Sainz-Mejias, M., Ma, C., Hou, Y., Jurado-Martin, I., Romerio, A., Franco, A., et al. (2025). Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge. ACS INFECTIOUS DISEASES, 11(4), 894-904 [10.1021/acsinfecdis.4c00932]. Dettaglio
Lami, F., Romerio, A., Italia, A., Shaik, M., Martin-Santamaria, S., Peri, F. (2024). Design, Synthesis and characterization of synthetic and natural derived TLR4 antagonists. Intervento presentato a: SCI 2024, Elements for the future - 26-30 agosto, Milano, Italia. Dettaglio
Shaik, M., Pasco, S., Romerio, A., Pifferi, C., Sesana, S., Re, F., et al. (2024). Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant. JOURNAL OF MEDICINAL CHEMISTRY, 67(24), 22254-22262 [10.1021/acs.jmedchem.4c02392]. Dettaglio